Latest Exome Asset Management LLC Stock Portfolio
Exome Asset Management LLC Performance:
2024 Q3: 4.26%YTD: 18.99%
Performance for 2024 Q3 is 4.26%, and YTD is 18.99%.
About Exome Asset Management LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Exome Asset Management LLC reported an equity portfolio of $145.6 Millions as of 30 Sep, 2024.
The top stock holdings of Exome Asset Management LLC are LLY, , BBIO. The fund has invested 6.4% of it's portfolio in ELI LILLY & CO and 4.5% of portfolio in ASCENDIS PHARMA A/S.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), CORBUS PHARMACEUTICALS HLDGS (CRBP) and TRAVERE THERAPEUTICS INC (TVTX) stocks. They significantly reduced their stock positions in GOSSAMER BIO INC (GOSS), BEIGENE LTD (BGNE) and CENTESSA PHARMACEUTICALS PLC (CNTA). Exome Asset Management LLC opened new stock positions in STRUCTURE THERAPEUTICS INC, ALIGN TECHNOLOGY INC (ALGN) and GILEAD SCIENCES INC (GILD). The fund showed a lot of confidence in some stocks as they added substantially to BRIDGEBIO PHARMA INC (BBIO), ASCENDIS PHARMA A/S and APELLIS PHARMACEUTICALS INC (APLS).
The top stock holdings of Exome Asset Management LLC are LLY, , BBIO. The fund has invested 6.4% of it's portfolio in ELI LILLY & CO and 4.5% of portfolio in ASCENDIS PHARMA A/S.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), CORBUS PHARMACEUTICALS HLDGS (CRBP) and TRAVERE THERAPEUTICS INC (TVTX) stocks. They significantly reduced their stock positions in GOSSAMER BIO INC (GOSS), BEIGENE LTD (BGNE) and CENTESSA PHARMACEUTICALS PLC (CNTA). Exome Asset Management LLC opened new stock positions in STRUCTURE THERAPEUTICS INC, ALIGN TECHNOLOGY INC (ALGN) and GILEAD SCIENCES INC (GILD). The fund showed a lot of confidence in some stocks as they added substantially to BRIDGEBIO PHARMA INC (BBIO), ASCENDIS PHARMA A/S and APELLIS PHARMACEUTICALS INC (APLS).
Exome Asset Management LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Exome Asset Management LLC made a return of 4.26% in the last quarter. In trailing 12 months, it's portfolio return was 45.75%.
New Buys
| Ticker | $ Bought |
|---|---|
| structure therapeutics inc | 5,274,040 |
| align technology inc | 4,755,780 |
| gilead sciences inc | 4,192,000 |
| geron corp | 4,109,270 |
| biontech se | 4,103,740 |
| bristol-myers squibb co | 4,035,720 |
| viridian therapeutics inc | 3,967,600 |
| blueprint medicines corp | 3,394,750 |
New stocks bought by Exome Asset Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| bridgebio pharma inc | 167 |
| ascendis pharma a/s | 119 |
| apellis pharmaceuticals inc | 114 |
| syros pharmaceuticals inc | 87.58 |
| adagene inc | 74.07 |
| rezolute inc | 24.67 |
| quanterix corp | 23.22 |
| pliant therapeutics inc | 20.65 |
Additions to existing portfolio by Exome Asset Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| gossamer bio inc | -58.46 |
| beigene ltd | -53.92 |
| centessa pharmaceuticals plc | -49.74 |
| amgen inc | -43.22 |
| insmed inc | -40.85 |
| kura oncology inc | -31.45 |
| tg therapeutics inc | -17.48 |
Exome Asset Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| autolus therapeutics plc | -2,921,360 |
| abcellera biologics inc | -1,524,100 |
| wave life sciences ltd | -2,435,790 |
| travere therapeutics inc | -3,644,580 |
| elevation oncology inc | -997,169 |
| pmv pharmaceuticals inc | -580,608 |
| fulcrum therapeutics inc | -1,876,740 |
| cabaletta bio inc | -2,245,500 |
Exome Asset Management LLC got rid off the above stocks
Sector Distribution
Exome Asset Management LLC has about 80.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 80.9 |
| Others | 19.1 |
Market Cap. Distribution
Exome Asset Management LLC has about 30.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 25.9 |
| LARGE-CAP | 21.4 |
| SMALL-CAP | 20.3 |
| UNALLOCATED | 19.1 |
| MEGA-CAP | 8.8 |
| MICRO-CAP | 3.7 |
Stocks belong to which Index?
About 70.1% of the stocks held by Exome Asset Management LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 45.9 |
| Others | 29.9 |
| S&P 500 | 24.2 |
Exome Asset Management LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Exome Asset Management LLC
Exome Asset Management LLC has 55 stocks in it's portfolio. About 36.2% of the portfolio is in top 10 stocks. APLS proved to be the most loss making stock for the portfolio. BGNE was the most profitable stock for Exome Asset Management LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGIO | agios pharmaceuticals inc | 2.02 | 66,200 | 2,941,270 | new | |||
| AKRO | akero therapeutics inc | 1.52 | 77,100 | 2,212,000 | new | |||
| ALGN | align technology inc | 3.27 | 18,700 | 4,755,780 | new | |||
| AMGN | amgen inc | 1.48 | 6,700 | 2,158,810 | reduced | -43.22 | ||
| APLS | apellis pharmaceuticals inc | 1.99 | 100,367 | 2,894,580 | added | 114 | ||
| APRE | aprea therapeutics inc | 0.26 | 137,174 | 377,229 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATEC | alphatec hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 3.69 | 211,000 | 5,372,060 | added | 167 | ||
| BCRX | biocryst pharmaceuticals inc | 1.02 | 196,500 | 1,493,400 | new | |||
| BGNE | beigene ltd | 2.36 | 15,300 | 3,435,000 | reduced | -53.92 | ||
| BIIB | biogen inc | 1.77 | 13,317 | 2,572,920 | new | |||
| BMY | bristol-myers squibb co | 2.77 | 78,000 | 4,035,720 | new | |||
| BPMC | blueprint medicines corp | 2.33 | 36,700 | 3,394,750 | new | |||
| CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CI | the cigna group | 2.90 | 12,200 | 4,226,570 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 1.52 | 138,152 | 2,209,050 | reduced | -49.74 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||